Brenner R, Hyman N, Knobler R, O'Brien M, Stephan T
Department of Neurology, Royal Free Hospital, London.
Hosp Med. 1998 Oct;59(10):778-82.
With the introduction of the antispasticity agent, tizanidine hydrochloride (Zanaflex), physicians have requested information about the optimal way to switch appropriate patients from baclofen to tizanidine. A group of neurologists and rehabilitation specialists with a particular interest in spasticity was therefore asked to draw up a suitable approach to changing treatment.
随着抗痉挛药物盐酸替扎尼定(Zanaflex)的引入,医生们要求了解将合适的患者从巴氯芬转换为替扎尼定的最佳方法。因此,一组对痉挛特别感兴趣的神经科医生和康复专家被要求制定一种合适的换药方法。